ORBIMED ADVISORS LLC Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$5.4T
Holdings
129
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (129 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | XBISPDR SER TR | 76,400 | $6.1B | 0.11% | |
| 102 | —SYNLOGIC INC | 6,029,995 | $5.7B | 0.11% | |
| 103 | CRVSCORVUS PHARMACEUTICALS INC | 6,943,654 | $5.7B | 0.11% | |
| 104 | CYBNEURCYBIN INC | 10,453,600 | $5.1B | 0.09% | |
| 105 | LLYLILLY ELI & CO | 15,000 | $4.8B | 0.09% | Call |
| 106 | HRTXHERON THERAPEUTICS INC | 1,123,000 | $4.7B | 0.09% | |
| 107 | SRRKSCHOLAR ROCK HLDG CORP | 667,943 | $4.6B | 0.09% | |
| 108 | APLTAPPLIED THERAPEUTICS INC | 4,250,000 | $4.0B | 0.07% | |
| 109 | —GRAYBUG VISION INC | 4,163,347 | $3.9B | 0.07% | |
| 110 | VIGLVIGIL NEUROSCIENCE INC | 411,191 | $3.7B | 0.07% | |
| 111 | 698ACHILLES THERAPEUTICS PLC | 1,463,251 | $3.3B | 0.06% | |
| 112 | AMRXAMNEAL PHARMACEUTICALS INC | 1,583,490 | $3.2B | 0.06% | |
| 113 | —MAGENTA THERAPEUTICS INC | 2,250,953 | $3.2B | 0.06% | |
| 114 | BNRBURNING ROCK BIOTECH LTD | 1,282,816 | $3.1B | 0.06% | |
| 115 | —HARPOON THERAPEUTICS INC | 3,025,908 | $2.9B | 0.05% | |
| 116 | DYNDYNE THERAPEUTICS INC | 220,400 | $2.8B | 0.05% | |
| 117 | GRPHGRAPHITE BIO INC | 848,412 | $2.7B | 0.05% | |
| 118 | TARAPROTARA THERAPEUTICS INC | 830,641 | $2.5B | 0.05% | |
| 119 | AFIBACUTUS MED INC | 2,648,386 | $2.3B | 0.04% | |
| 120 | —LOGICBIO THERAPEUTICS INC | 8,466,783 | $2.3B | 0.04% | |
| 121 | PYXSPYXIS ONCOLOGY INC | 848,252 | $1.7B | 0.03% | |
| 122 | —ONCOCYTE CORP | 1,882,768 | $1.4B | 0.03% | |
| 123 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $1.4B | 0.03% | |
| 124 | EPIEURESSA PHARMA INC | 640,645 | $1.2B | 0.02% | |
| 125 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 771,059 | $1.1B | 0.02% | |
| 126 | GLUEMONTE ROSA THERAPEUTICS INC | 117,455 | $960.0M | 0.02% | |
| 127 | PHGEBIOMX INC | 2,813,489 | $957.0M | 0.02% | |
| 128 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,797,221 | $945.0M | 0.02% | |
| 129 | VORVOR BIOPHARMA INC | 111,808 | $445.0M | 0.01% | |
| 130 | —LONGBOARD PHARMACEUTICALS IN | 113,500 | $422.0M | 0.01% |
PreviousPage 2 of 2